Total words: 3723 | 2-word phrases: 949 | 3-word phrases: 1111 | 4-word phrases: 1184
| Title | Try to keep the title under 60 characters (53 characters) Kodiak Sciences - Novel medicines for retinal disease |
| Description | Try to keep the meta description between 50 - 160 characters (141 characters) Our novel therapies for retinal disease are designed to restore vision, stop progression of underlying disease, and require fewer treatments. |
| Keywords | Meta keywords are not recommended anymore (0 characters) |
| H1 | No H1 tag on the page (0 characters) |
| # | Keyword | H1 | Title | Des | Volume | Position | Suggest | Frequency | Density |
|---|---|---|---|---|---|---|---|---|---|
| 1 | and | 61 | 12.73% | ||||||
| 2 | of | 50 | 10.44% | ||||||
| 3 | the | 43 | 8.98% | ||||||
| 4 | kodiak | 37 | 7.72% | ||||||
| 5 | in | 34 | 7.10% | ||||||
| 6 | our | 32 | 6.68% | ||||||
| 7 | sciences | 29 | 6.05% | ||||||
| 8 | to | 29 | 6.05% | ||||||
| 9 | retinal | 27 | 5.64% | ||||||
| 10 | tarcocimab | 21 | 4.38% |
| # | URL | Whois | Check |
|---|---|---|---|
| 1 | https://kodiak.gcs-web.com/esg-report | Whois | gcs-web.com |
| 2 | https://kodiak.gcs-web.com/esg-report | Whois | gcs-web.com |
| 3 | https://kodiak.gcs-web.com/news-releases/news-release-details/kodiak-sciences-expands-development-pipeline-treatment-first | Whois | gcs-web.com |
| 4 | https://kodiak.gcs-web.com/news-releases/news-release-details/grand-opening-kodiak-sciences-purpose-built-bioconjugation | Whois | gcs-web.com |
| 5 | https://kodiak.gcs-web.com/news-releases/news-release-details/kodiak-sciences-expands-development-pipeline-treatment-first | Whois | gcs-web.com |
| 6 | https://kodiak.gcs-web.com/news-releases/news-release-details/grand-opening-kodiak-sciences-purpose-built-bioconjugation | Whois | gcs-web.com |
| 7 | https://kodiak.gcs-web.com/news-releases/news-release-details/kodiak-sciences-present-upcoming-investor-and-clinical | Whois | gcs-web.com |
| 8 | https://kodiak.gcs-web.com/news-releases/news-release-details/kodiak-sciences-announces-treatment-first-patients-phase-3-glow2 | Whois | gcs-web.com |
| 9 | http://kodiak.gcs-web.com/news-releases/news-release-details/kodiak-sciences-announces-upcoming-presentation-first-time | Whois | gcs-web.com |
| 10 | https://kodiak.gcs-web.com/news-releases/news-release-details/kodiak-sciences-present-upcoming-investor-and-clinical | Whois | gcs-web.com |
| 11 | https://kodiak.gcs-web.com/news-releases/news-release-details/kodiak-sciences-announces-treatment-first-patients-phase-3-glow2 | Whois | gcs-web.com |
| 12 | http://kodiak.gcs-web.com/news-releases/news-release-details/kodiak-sciences-announces-upcoming-presentation-first-time | Whois | gcs-web.com |